WCN26-5056 URINARY LIPIDOMICS MIGHT SERVE AS A USEFUL LABORATORY SYSTEM, DISCRIMINATING BETWEEN IgA AND DIABETIC NEPHROPATHIES

Read full text Summarise with VIRAT
Authors: Yoshifumi Morita, Teruhiko Yoshida, Yoshifumi Hamasaki, Masaomi Nangaku, Yoshikazu Ono, Makoto Kurano
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Noninvasive laboratory testing is desirable to diagnose kidney diseases and reduce reliance on invasive renal biopsy. IgA nephropathy (IgAN) and diabetic nephropathy (DN) are the two major causes of hemodialysis initiation in Japan. Although corticosteroids are commonly used to treat IgAN, patients often develop steroid-induced diabetes mellitus (DM), and there are overlapping pathological mechanisms of IgAN and DN in which the primary cause of kidney injury cannot be distinguished. Therefore, differentiating IgAN from DN is crucial to guide treatment and prevent disease progression.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104348–104348
Publication date
25 March 2026
Language
EN